Trials / Unknown
UnknownNCT00595348
Korean Hereditary Breast Cancer Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,250 (estimated)
- Sponsor
- Korean Breast Cancer Study Group · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Accepted
Summary
1. To evaluate the prevalence of BRCA1/2 mutation of breast cancer patients with family history of breast/ovarian cancer. 2. To evaluate the prevalence of BRCA1/2 mutation of breast cancer patients without family history, but high risk of hereditary cancer. 3. To evaluate the prevalence of BRCA1/2 mutation of family member of BRCA1/2 mutation. 4. To evaluate the prevalence of ovarian cancer of population of above 3 groups.
Detailed description
1. To find founder mutation in Korean 2. To correlation prevalence with risk evaluation 3. To find risk factors concerning life style
Conditions
Timeline
- Start date
- 2007-11-01
- Primary completion
- 2012-05-01
- Completion
- 2017-05-01
- First posted
- 2008-01-16
- Last updated
- 2011-05-11
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00595348. Inclusion in this directory is not an endorsement.